Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or...
Reexamination Certificate
2005-07-12
2005-07-12
Leary, Louise N. (Department: 1654)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
C435S975000, C530S300000, C530S329000, C530S328000, C530S356000
Reexamination Certificate
active
06916604
ABSTRACT:
Peptides synthesized to match the human α1 (I) and α2 (I) amino-telopeptide sequences of type I collagen degradation products in body fluids, preferably either Asp-GIu-Lys-Ser-Thr-Gly-Gly (SEQ ID NO:5) or Gln-Tyr-Asp-Gly-Lys-Gly-Val-Gly (SEQ ID NO:6). used as calibrators and antigens in immunoassays for detecting type I collagen degradation products in body fluids.
REFERENCES:
patent: 3600132 (1971-08-01), Goverde
patent: 4094646 (1978-06-01), Stern et al.
patent: 4298593 (1981-11-01), Ling
patent: 4312853 (1982-01-01), Timpl
patent: 4371374 (1983-02-01), Cerami et al.
patent: 4504587 (1985-03-01), Timpl et al.
patent: 4628027 (1986-12-01), Gay
patent: 4731326 (1988-03-01), Thompson et al.
patent: 4774227 (1988-09-01), Piez et al.
patent: 5140103 (1992-08-01), Eyre
patent: 5300434 (1994-04-01), Eyre
patent: 5320970 (1994-06-01), Eyre
patent: 5455179 (1995-10-01), Eyre
patent: 5472884 (1995-12-01), Eyre
patent: 5532169 (1996-07-01), Eyre
patent: 5576189 (1996-11-01), Eyre
patent: 5607862 (1997-03-01), Eyre
patent: 5677198 (1997-10-01), Eyre
patent: 5962639 (1999-10-01), Eyre
patent: 6048705 (2000-04-01), Eyre
patent: 6110689 (2000-08-01), Qvist et al.
patent: 6204367 (2001-03-01), Eyre
patent: 6355442 (2002-03-01), Qvist et al.
patent: 128 041 (1983-06-01), None
patent: 289 314 (1988-04-01), None
patent: 505210 (1992-09-01), None
patent: 424428 (1994-09-01), None
patent: 394296 (1995-01-01), None
patent: 502928 (1996-01-01), None
patent: 2205643 (1998-12-01), None
patent: WO 88/08980 (1988-11-01), None
patent: WO 89/04491 (1989-05-01), None
patent: WO 89/12824 (1989-12-01), None
patent: WO 90/04417 (1990-05-01), None
patent: WO 90/08195 (1990-07-01), None
patent: WO 91/08478 (1991-06-01), None
patent: WO 92/21698 (1992-12-01), None
U.S. Appl. No. 07/432,044, filed Nov. 3, 1989, Termine.
Ala-Kokko, et al., “Structure of cDNA clones coding for the entire preproa1 (III) chain of human type III procollagen: Differences in protein structure from type I procollagen and conservation of codon preferences,”Biochemistry Journal,260:509-516 (1989).
Seibel, “Komponenten der extrazllularen Gewebematrix als potentielle ‘Marker’ des Bindegewebs-, Knorpel- und Knochenmetabolismus bei Erkrankungen des Bewegungsapparates,”Zeitschrift fur Rheumatologie,48:6-18 (1989).
Dodge and Poole, “Immunohistochemical Detection and Immunochemical Analysis of Type II Collagen Degradation in Human Normal, Rheumatoid and Osteoarthritic Articular Cartilages and in Explants of Bovine Articular Cartilage Cultured with Interleukin 1,” Journal of Clinical Investigation, 83:647-661 (1989).
Niemela, “Radioimmunoassays for Type III Procollagen Amino-Terminal Peptides In Humans,”Clinical Chemistry,31:1301-1304 (1985).
Sangiorgi, et al., “Isolation and partial characterization of the entire human proa1(II) collagen gene,”Nucleic Acids Research,13:2207-2225 (1985).
Loidl, et al., “Molecular cloning and carboxyl-propeptide analysis of human type III procollagen,”Nucleic Acids Research,12:9383-9393 (1984).
Wu and Eyre, “Identification of Hydroxypyridinium Cross-Linking Sites in Type II Collagen of Bovine Articular Cartilage,”Biochemistry,23:1850-1857 (1984).
Pierard, et al., “Radioimmunoassay for the Amino-Terminal Sequences of Type III Procollagen in Human Body Fluids Measuring Fragmented Precursor Sequences,”Analytical Biochemistry,141:127-136 (1984).
Rohde, et al., “Radioimmunoassay for type III procollogen peptide and its application to human liver disease,”European Journal of Clinical Investigation,9:451-459 (1979).
Russell, R.G.G., et al., “Biochemical Markers of Bone Turnover in Paget's Disease,”Metab. Bone Dis.&Rel. Res.,4 & 5:255-262 (1981).
Drinkwater, B.L., et al., “Bone Mineral Density After Resumption of Menses in Amenorrheic Athletes,”JAMA,256:380-382 (1986).
Drinkwater, B.L., et al., “Bone Mineral Content of Amenorrheic and Eumenorrheic Athletes,” theNew England Journal of Medicine,311:5; 277-281 (1984).
Fujimoto, D., “Evidence for Natural Existence of Pyridinoline Crosslink in Collagen,”Biochemical and Biophysical Research Communications,93:948-953 (1980).
Yamauchi, M. et al., “A Comparative Study of the Distribution of the Stable Crosslink, Pyridinoline, in Bone Collagens from Normal, Osteoblastoma, and Vitamin D-Deficient Chicks,”Biochemical and Biophysical Research Communications,102:59-65 (1981).
Kuboki, Y., et al., “Location of the Intermolecular Crosslinks in Bovine Dentin Collagen, Solubilization with Trypsin and Isolation of Cross-Link Peptides Containing Dihydroxylysinonorleucine and Pyridinoline,”Biochemical and Biophysical Research Communications,102:119-126 (1981).
Gunja-Smith, Z. and Boucek, R.J., “Collagen cross-linking compounds in human urine,”Biochemical Journal,197:759-762 (1981).
Tsuchikura, O., et al., “Pyridinoline Fluorescence in Cyanogen Bromide Peptides of Collagen,”Biochemical and Biophysical Research Communications,102:1203-1208 (1981).
Tsuda, M., et al., “Pyridinoline is a Real Moiety of Collagen,”Biochemical and Biophysical Research Communications,104:1407-1412 (1982).
Robins, S.P., “An enzyme-linked immunoassay for the collagen cross-link pyridinoline,”Biochemical Journal,207:617-620 (1982).
Banes, A.J., et al., “Nonmineralized and Mineralized Compartments of Bone: the Role of Pyridinoline in Nonmineralized Collagen,”Biochemical and Biophysical Research Communications,113:975-981 (1983).
Fujimoto, D., et al., “Analysis of Pyridinoline, a Cross-Linking Compound of Collagen Fibers, in Human Urine,”J. Biochem.,94:1133-1136 (1983).
Eyre, D.R., et al., “Cross-Linking in Collagen and Elastin,”Ann. Rev. Biochem.,53:717-748 (1984).
Light, N. and Bailey, A.J., “Collagen crosslinks: Location of pyridinoline in type I collagen,”FEBS2409, 182:503-508 (1985).
Wu, J-J. and Eyre, D.R., “Fine Powdering Exposes the Mineral-Protected Collagen of Bone to Protease Digestion,”Calcif. Tissue Int.,42:243-247 (1988).
Fujimoto, D., et al., “Pyridinoline, A Non-Reducible Crosslink of Collagen. Quantitative Determination, Distribution, and Isolation of a Crosslinked Peptide,”Chemical Abstracts89(11):148, (Sep. 11, 1978).
Black, D., et al., “Quantitative Analysis of the Pyridinium Crosslinks of Collagen in Urine Using Ion-Paired Reversed-Phase High-Performance Liquid Chromatography,”Chemical Abstracts108(21):354, (May 23, 1988).
Fujimoto, D., et al., “Analysis of Pyridinoline, A Cross-Linking Compound of Collagen Fibers, in Human Urine,”Chemical Abstracts99(19):446-447, (Nov. 7, 1983).
Macek, J., et al., “Determination of Collagen Degradation Products in Human Urine in Osteoarthrosis,”Chemical Abstracts108(3):299, (Jan. 18, 1988).
Eyre, D.R., et al., “Quantitation of Hydroxypyridinium Crosslinks in Collagen by High-Performance Liquid Chromatography,”Analytical Biochemistry,137:380-388 (1984).
Robins, S.R., et al., “Measurement of the cross linking compound, pyridinoline, in urine as an index of collagen degradation in joint disease,”Annals of the Rheumatic Diseases,45:969-973 (1986).
Bernard, M.P., et al., “Nucleotide Sequences of Complementary Deoxyribonucleic Acids for the Proa1 Chain of Human Type I Procollagen. Statistical Evaluation of Structures that are Conserved During Evolution,”Biochemistry,22:5213-5223 (1983).
Goldstein, D., et al., “Simultaneous Measurement of DOPA, DOPAC, and Catecholamines in Plasma by Liquid Chromatography with Electrochemical Detection,”ESA Review,vol. II, No. 1, pp. 2-11 (1986).
Chu, M-L., et al., “Human proal(I) collagen gene structure reveals evolutionary conservation of pattern of introns and exons,”Nature310(26):337-340 (1984).
Robins, S.P., et al., “Measurement of Hydroxypy
Christensen O'Connor Johnson & Kindness PLLC
Leary Louise N.
Washington Research Foundation
LandOfFree
Uses of synthetic peptides corresponding to telopeptide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Uses of synthetic peptides corresponding to telopeptide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of synthetic peptides corresponding to telopeptide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3368514